| Application no. and date | 21733160.2 (espacenet) (Federated) (European Patent Register), 20210624 | | Patent/reg. no. and date | DK/EP 4171559, 20250910 | | Publication date | 20230503 | | Priority no. and date | EP 20182067, 20200624 | | EP pub. no. and date |
EP 4171559 20230503 | | Effective date | | | Applicant/owner | Zevra Denmark A/S, Nordre Fasanvej 215, 2000 Frederiksberg, DK | | Applicant ref. no. | P5716DKEP01 | | Inventor | JENSEN, Thomas, Kirkegaard, 2610 Rødovre, DK,
HINSBY, Anders, Mørkeberg, 2900 Hellerup, DK,
FOG-TÿNNESEN, Cathrine, Kolster, 2830 Virum, DK,
INGEMANN, Linda, 2870 Dyssegård, DK,
Ã? DALI, Christine, 1316 København K, DK | | Representative | HØIBERG P/S, Adelgade 12, 1304 København K | | Opponent | | | IPC Class | A61K 31/4545 (2006.01) , A61K 45/06 (2006.01) , A61P 25/00 (2006.01) , A61P 3/00 (2006.01) , A61P 43/00 (2006.01) | | Title | Arimoclomol til behandling af Gauchers sygdom | | Int. application no. | EP2021067366 | | Int. publication no. | WO2021260120 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
